First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers
Drug Design, Development and Therapy · 2026-10 · Volume 20 · 1-15
DOI: 10.2147/dddt.s631473 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2026-10. Verfasst von Sooyoun Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Nanoparticles, SARS-CoV-2. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
- Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
- Lemonex Inc., Institute of Biotherapeutics Convergence Technology, Seoul, Republic of Korea.
ORCID-Profile: Sooyoun Lee, Ki Young Huh, Kyung-Sang Yu, Dal-Hee Min, Cheolhee Won, In-Jin Jang
Zitieren
APA
Lee, S., Huh, K. Y., Yu, K. S., Min, D. H., Won, C., & Jang, I. J. (2026). First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers. Drug Design, Development and Therapy, Volume 20, 1-15. https://doi.org/10.2147/dddt.s631473
Vancouver
Lee S, Huh KY, Yu KS, Min DH, Won C, Jang IJ. First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers. Drug Design, Development and Therapy. 2026;Volume 20:1-15. doi:10.2147/dddt.s631473
BibTeX
@article{Lee2026,
author = {Lee, Sooyoun and Huh, Ki Young and Yu, Kyung-Sang and Min, Dal-Hee and Won, Cheolhee and Jang, In-Jin},
title = {First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--15},
doi = {10.2147/dddt.s631473}
}
EUVIMED